ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

SoftBank invests $900m more in Nasdaq-listed US gene tech maker

Pacific Biosciences shares soar following latest fundraising from Japanese group

SoftBank Group has focused more on public companies recently, looking to diversify its investments. (Photo by Yoichi Iwata)

TOKYO -- Japan's SoftBank Group will invest $900 million in a U.S. developer of equipment for genetic analysis, building on its earlier investment in the company.

Nasdaq-listed Pacific Biosciences of California said Wednesday that SoftBank Group agreed to buy convertible bonds through subsidiary SB Management.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more